Researchers tied sleep and circadian disruption to impaired brain clearance mechanisms relevant to Parkinson’s disease. The work, led by Zafar and Schneider and slated for publication in npj Parkinson’s Disease, connects sleep-circadian rhythms with autophagy and glymphatic system function, which together regulate how waste and protein aggregates are cleared from the brain. The study’s central claim is that disrupting the sleep–circadian program can compromise clearance pathways, potentially changing the biological environment in which neurodegeneration progresses. The focus adds mechanistic weight to clinical observations that sleep problems often emerge alongside Parkinson’s. For drug developers and investigators, the report reinforces interest in sleep/circadian modulation as both a disease biomarker and a potential therapeutic lever—though the report itself focuses on mechanistic biology rather than interventions.